Reports Q1 revenue $317M, consensus $272.84M. “We are encouraged by our first quarter results, which reflect the progress we are making against Phase II of the Indivior (INDV) Action Agenda – Accelerate,” said Joe Ciaffoni, Chief Executive Officer. “Year-over-year we accelerated SUBLOCADE net revenue and dispense unit growth and grew adjusted EBITDA and cash at an even faster rate while executing on our capital deployment strategy. We remain focused on accelerating SUBLOCADE dispense unit growth, growing our bottom line at a significantly faster rate, and strategically deploying capital as we earn our way to Phase III of the Indivior Action Agenda – Breakout – which we are on track to enter in the second half of 2026.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INDV:
- Indivior presents real world data on injectable buprenorphine at ASAM Conference
- Indivior Issues $500 Million Convertible Senior Notes Offering
- Indivior Prices Upsized Convertible Notes for Debt Refinancing
- Indivior Announces $400 Million Convertible Notes and Buyback
- Indivior announces proposed convertible senior notes offering
